SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043994
Filing Date
2021-08-12
Accepted
2021-08-12 16:19:15
Documents
43
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20210630.htm   iXBRL 10-Q 1246747
2 EX-31.1 evok-ex311_7.htm EX-31.1 9581
3 EX-31.2 evok-ex312_9.htm EX-31.2 9864
4 EX-32.1 evok-ex321_6.htm EX-32.1 5032
5 EX-32.2 evok-ex322_8.htm EX-32.2 5250
6 GRAPHIC grjmya22ql5h000001.jpg GRAPHIC 42675
  Complete submission text file 0001564590-21-043994.txt   3887951

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20210630.xsd EX-101.SCH 31192
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20210630_cal.xml EX-101.CAL 25651
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20210630_def.xml EX-101.DEF 85225
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20210630_lab.xml EX-101.LAB 225996
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20210630_pre.xml EX-101.PRE 165820
12 EXTRACTED XBRL INSTANCE DOCUMENT evok-10q_20210630_htm.xml XML 536171
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 211167845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences